首页> 外文期刊>Neues Jahrbuch fur Mineralogie, Abhandlungen >Crystal structures of monoclinic variants of two SFCA structure-types containing significant Fe2+: crystal structure of monoclinic SFCA-II, Ca2.6Fe8.03+Fe3.42+Al4O24; and proposed crystal structure of monoclinic SFCA-I, ideally, Ca2Fe82+Fe83+Al4O28
【24h】

Crystal structures of monoclinic variants of two SFCA structure-types containing significant Fe2+: crystal structure of monoclinic SFCA-II, Ca2.6Fe8.03+Fe3.42+Al4O24; and proposed crystal structure of monoclinic SFCA-I, ideally, Ca2Fe82+Fe83+Al4O28

机译:含有显着Fe2 +的两个SFCA结构类型的单斜晶体变体的晶体结构:单斜斜晶SFCA-II的晶体结构,Ca2.6Fe8.03 + Fe3.42 + Al4O24; 并提出的单斜晶晶体结构,理想情况下,Ca2Fe82 + Fe83 + Al4O28

获取原文
获取原文并翻译 | 示例
       

摘要

Determination of the crystal structure of a new calcium alumoferrite has proved it to be a monoclinic variant of the previously determined SFCA-type. triclinic SFCA-II. It has formed during firing mixtures of ternary phase compositions in the CaO-Fe2O3-Al2O3 system (CF(2)A) under reducing conditions. Monoclinic SFCA-II has the cell dimensions a = 10.335, b = 17.987, c = 10.488 A, beta = 109.50 degrees, V = 1838 A(3), Z = 8, and space group symmetry P2/n. Its composition, determined from the crystal structure refinement, is Ca1.2Fe4.03+Fe1.82+ A1(2)O(12), (M9O12). Monoclinic SFCA-II is a disordered structure composed of polysomatic sequences of pyroxene (P) and spinel (S) modules and, in this context, may be represented by the polysomatic formulation SSPSP. Further, a crystal structure for a monoclinic variant of triclinic SFCA-I is proposed. The unit cell dimensions of this phase are a = 10.34, b = 21.44, c = 10.50 A, beta = 109.96 degrees, P2(I)/n symmetry. The ideal composition of this phase is Ca2Fe82+Fe3+ (8)A1(4)O(28), (M11O14). In this case the structure may be represented by the polysomatic formulation of pyroxene (P) and spinel (S) modules as SSPSSP.
机译:已经证明了新的氧化铝氧化铝的晶体结构的测定是预先确定的SFCA型的单斜晶体变体。三级SFCA-II。在降低条件下在CaO-Fe 2 O 3-Al2O3体系中的三元相组合物(CF(2)A)中的三元相组合物的混合物中形成。单醚SFCA-II具有细胞尺寸A = 10.335,B = 17.987,C = 10.488A,β= 109.50度,V = 1838A(3),Z = 8和空间组对称P2 / N。其组合物由晶体结构细化确定为Ca1.2Fe4.03 + Fe1.82 + A1(2)O(12),(M9O12)。单醚SFCA-II是由辉石(P)和尖晶石和尖晶石模块的多源性序列组成的无序结构,并且在这种情况下,可以由多种族配方表示。此外,提出了三态SFCA-1的单斜晶体变体的晶体结构。该相的单位细胞尺寸是A = 10.34,B = 21.44,C = 10.50A,β= 109.96度,P2(I)/ n对称。该相的理想组合物是Ca2Fe82 + Fe3 +(8)A1(4)O(28)(M11O14)。在这种情况下,该结构可以由辉石(P)和尖晶石模块的多染色制剂作为& Sspssp&

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号